[{"data":1,"prerenderedAt":14},["ShallowReactive",2],{"blog-regulatory-signal-intelligence-b2b-leads":3},{"category":4,"content":5,"date":6,"description":7,"faq":8,"ogTitle":9,"readTime":10,"slug":11,"tags":12,"title":9},"Regulatory Compliance","\u003Ch2 class=\"text-3xl font-bold mb-6\">What Is Regulatory Signal Intelligence?\u003C\u002Fh2>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Every day, regulatory authorities worldwide publish thousands of regulatory signals: FDA clearances, EUDAMED certificates, patent grants, clinical trial registrations. Most B2B sales teams ignore this data — yet it contains the most precise leading indicators for technology-sector business opportunities.\n            \u003C\u002Fp>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Regulatory Signal Intelligence (RSI) is the approach of systematically capturing these public signals, semantically contextualizing them, and translating them into concrete lead scoring.\n            \u003C\u002Fp>\n\n            \u003Ch2 class=\"text-3xl font-bold mb-6 mt-12\">Three Use Cases\u003C\u002Fh2>\n\n            \u003Ch3 class=\"text-2xl font-bold mb-4 mt-8\">1. Lead Generation from FDA Clearances\u003C\u002Fh3>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              When an IVD manufacturer receives a 510(k) clearance for a new SARS-CoV-2 test, demand immediately arises: reagents, consumables, logistics partners. Whoever recognizes this signal before the competition responds gains a time advantage of weeks to months.\n            \u003C\u002Fp>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              An example: The FDA clearance \u003Ccode class=\"text-primary-600 dark:text-primary-400 bg-slate-100 dark:bg-slate-800 px-1 rounded\">K240123\u003C\u002Fcode> for a rapid antigen test signals not only the manufacturer's success — it also reveals which CDMOs and reagent suppliers are now in demand. Understanding the relationship between product type, technology class, and clearance pathway allows anticipating this demand.\n            \u003C\u002Fp>\n\n            \u003Ch3 class=\"text-2xl font-bold mb-4 mt-8\">2. Competitive Intelligence\u003C\u002Fh3>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Competitors' patent grants and FDA clearances reveal the technological directions in which the market is moving. A cluster of new patents on \"Lateral Flow with Quantum Dot Labeling\" across multiple competitors is a clear signal of an impending technology shift.\n            \u003C\u002Fp>\n\n            \u003Ch3 class=\"text-2xl font-bold mb-4 mt-8\">3. Grant Discovery\u003C\u002Fh3>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Funding programs are regulatory signals at another level: When BMBF announces a new focus area \"AI in Medical Technology,\" it signals research demand. CI recognizes such patterns and matches them against the customer's technology profile.\n            \u003C\u002Fp>\n\n            \u003Ch2 class=\"text-3xl font-bold mb-6 mt-12\">Why Keyword Search Is Not Enough\u003C\u002Fh2>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Traditional approaches fail due to three problems:\n            \u003C\u002Fp>\n            \u003Col class=\"space-y-3 text-slate-600 dark:text-slate-400 mb-8 list-decimal pl-6\">\n              \u003Cli>\u003Cstrong>Synonyms\u003C\u002Fstrong>: \"In-vitro diagnostics,\" \"IVD,\" \"laboratory diagnostics,\" and \"clinical chemistry\" describe similar concepts — a keyword search only finds exact matches.\u003C\u002Fli>\n              \u003Cli>\u003Cstrong>Context\u003C\u002Fstrong>: An FDA clearance for \"Nucleic Acid Amplification Test\" is relevant to a manufacturer of PCR kits — but only if you know the relationship between \"NAAT\" and \"PCR.\"\u003C\u002Fli>\n              \u003Cli>\u003Cstrong>Cross-domain connections\u003C\u002Fstrong>: Funding programs often address multiple technology fields simultaneously (e.g., \"bioeconomy + AI + materials science\"). Those who miss these connections lose opportunities.\u003C\u002Fli>\n            \u003C\u002Fol>\n\n            \u003Ch2 class=\"text-3xl font-bold mb-6 mt-12\">How CI Uses Regulatory Signal Intelligence\u003C\u002Fh2>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Contextual Intelligence combines 22 public data sources (FDA, EUDAMED, ClinicalTrials.gov, patents, funding databases) in a semantic knowledge graph. Instead of keyword search, the system uses foundation model embeddings and graph traversal to find connections that keyword search overlooks.\n            \u003C\u002Fp>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-6 leading-relaxed\">\n              Each lead is automatically classified as HOT \u002F WARM \u002F COLD — based on the semantic proximity to the customer's technology profile, not rigid firmographic rules.\n            \u003C\u002Fp>\n            \u003Cp class=\"text-slate-600 dark:text-slate-400 mb-8 leading-relaxed\">\n              The underlying data (ORSD — Open Regulatory Signal Dataset) is openly licensed (ODbL) and freely usable. The premium product lies in the contextual evaluation and prioritization of signals — not in the raw data.\n            \u003C\u002Fp>","2026-01-01","Regulatory Signal Intelligence uses public regulatory data such as FDA clearances and EUDAMED certificates as leading indicators for B2B lead generation in the deep-tech space.",null,"Regulatory Signal Intelligence for B2B Leads",3,"regulatory-signal-intelligence-b2b-leads",[13],"regulatory-compliance",1786979507459]